Quadron Cannatech Expands Products to Capitalize on Extracts
Ryan Allway
June 13th, 2018
News, Top Story
There’s little doubt that cannabis extracts account for a growing percentage of the North American cannabis market. In Canada, extracts accounted for about 60 percent of all cannabis sales, as of the third quarter of last year (the latest data available). In the U.S., cannabis extracts have become increasingly popular in California, Nevada, and other markets where consumers are looking for alternatives to smoking cannabis.
Quadron Cannatech Corp. (CSE: QCC) is a Vancouver-based provider of equipment, products and service solutions for the authorized cannabis industry, providing a full array of end-to-end extraction and processing solutions, including sales of end user delivery options (such as vapor pens) for medical and recreational consumers. With a growing product portfolio, the company is uniquely positioned to capitalize on this growing demand over the coming years.
Growing Market for Extracts
Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of recreational cannabis use this summer. While cannabis flower characterized the market in the early years, cannabis extracts have become increasingly popular and eclipsed cannabis flower sales this year. These products are commonly used in vaporizers or edible products that may be more accessible to consumers.
According to Health Canada, cannabis extract sales rose from about 50 percent of total cannabis sales in the first quarter to about 60 percent of sales by the third quarter of last year (the latest data available). Cannabis oil inventories were also much thinner than cannabis flower – 11,140 kg versus 38,927 kg – which suggests that cannabis extract pricing could be more favorable and consumer demand may have been higher than expected.
Quadron provides turn key cannabis extraction equipment and processing solutions, as well as consumer products (such as vape pens), to licensed cannabis producers. Its flagship BOSS supercritical C02 extraction system combines proprietary max flow technology and advanced thermodynamics, automate features, and an exclusive plug and play design to create an industry-leading solution.
Over the past few quarters, the company has seen growing demand for its BOSS CO2 Extraction System and is co-developing several new pieces of equipment for commercial release into the North American market in conjunction with Washington-based Lucid Labs. This equipment includes an automated ethanol extraction system, advanced filtration system, distillation system, and an automated hydrocarbon extraction unit.
Quadron Places First Mobile Unit
Quadron recently announced the sale of its first mobile extraction module to TLC Botanicals. The First Nation holistic family-owned company is working with both First Nations and conventional patients to provide medical cannabis to patients under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). The company plans on providing these products through its subsidiary, Shamans First Choice dispensary.
“It was a pleasure working alongside the Quadron team in the purchase of our new extraction unit,” said TLC Botanicals General Manager Dave Campbell in the press release announcing the deal. “The professionalism they showed us was evident as they took our customized order and made the necessary adjustments to maximize the production levels we require. We look forward to future dealings with Quadron and its great team.”
“Through innovative engineering, and by leveraging our extraction and processing knowledge and expertise, we’ve designed a turn-key, drop in place, fully-functioning extraction environment,” said Quadron CEO Rosy Mondin. “The end result is a processing solution that serves a growing demand within the cannabis industry, enabling participants to process plants for terpenes and other cannabis compounds in a safe and professional setting.”
Looking Ahead
Quadron Cannatech Corp. (CSE: QCC) represents a compelling investment opportunity within the global cannabis industry. With extracts quickly becoming the most popular form of cannabis, the company’s innovative BOSS CO2 Extraction System continues to see strong demand from clients in Canada and around the world. The sale of its first mobile extraction unit marks a further expansion into the market.
For more information, visit the company’s website or download their investor presentation.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Aleafia, a vertically integrated, national cannabis company, operates major medical clinic, cannabis cultivation and R&D facilities.
TransCanna™ specializes in assisting clients who are cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
